Effect of interleukin 6 deficiency on the expression of Bcl-2 and Bax in the murine heart

Pharmacological Reports

Volumn 61, Issue 3, 2009, Pages 504-513

  Kamiński, Karol A ^a   Kozuch, Marcin ^a   Bonda, Tomasz A ^a   Stepaniuk, Maria M ^a   Waszkiewicz, Ewa ^a   Chyczewski, Lech ^a   Musiał, Włodzimierz J ^a   Winnicka, Maria M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Apoptosis; Heart; Interleukin 6; Ischemia and reperfusion; Mice

Indexed keywords

INTERLEUKIN 6; PROTEIN BAX; PROTEIN BCL 2; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; STRAIN DIFFERENCE; WESTERN BLOTTING; WILD TYPE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; DISEASE MODELS, ANIMAL; HEART VENTRICLES; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS; REPERFUSION INJURY; STAT3 TRANSCRIPTION FACTOR;

EID: 67651175986     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70093-3     Document Type: Article

References (25)

1. Arikan AA, Yu B, Mastrangelo MA, Tweardy DJ: Interleukin-6 treatment reverses apoptosis and blunts susceptibility to intraperitoneal bacterial challenge following hemorrhagic shock. Crit Care Med, 2006, 34, 771-777.
2. Carey AL, Steinberg GR, Macaulay SL, Thomas WG, Holmes AG, Ramm G, Prelovsek O et al.: Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMPactivated protein kinase. Diabetes, 2006, 55, 2688-2697.
3. Dawn B, Xuan YT, Guo Y, Rezazadeh A, Stein AB, Hunt G, Wu WJ et al.: IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res, 2004, 64, 61-71.
4. Deten A, Volz HC, Briest W, Zimmer HG: Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res, 2002, 55, 329-340.
5. Fuchs M, Hilfiker A, Kaminski K, Hilfiker-Kleiner D, Guener Z, Klein G, Podewski E et al.: Role of interleukin-6 for LV remodeling and survival after experimental myocardial infarction. FASEB J, 2003, 17, 2118-2120.
6. Hilfiker-Kleiner D, Hilfiker A, Fuchs M, Kaminski K, Schaefer A, Schieffer B, Hillmer A et al.: Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res, 2004, 95, 187-195.
7. Hong F, Kim WH, Tian Z, Jaruga B, Ishac E, Shen X, Gao B: Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene, 2002, 21, 32-43.
8. Hryniewicz A, Bialuk I, Kaminski KA, Winnicka MM: Impairment of recognition memory in interleukin-6 knock-out mice. Eur J Pharmacol, 2007, 577, 219-220.
9. Huber SA, Sakkinen P, Conze D, Hardin N, Tracy R: Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol, 1999, 19, 2364-2367.
10. Kaminski KA, Bonda TA, Korecki J, Musial WJ: Oxidative stress and neutrophil activation - the two keystones of ischemia/reperfusion injury. Int J Cardiol, 2002, 86, 41-59.
11. Kaminski KA, Oledzka E, Białobrzewska K, Kozuch M, Musiał WJ, Winnicka MM: The effects of moderate physical exercise on cardiac hypertrophy in interleukin 6 deficient mice. Adv Med Sci, 2007, 52, 164-168.
12. Kamiński KA, Usowicz-Szaryńska M, Kozuch M, Bonda T, Karwowski W, Chyczewski L, Sawicki B et al.: Preconditioning with the low dose of lipopolysaccharide attenuates apoptosis in heart during septic shock in mice. Pharmacol Rep, 2007, 59 (Suppl 1), 161-166.
13. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R et al.: Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature, 1994, 368, 339-342.
14. Kovacs P, Bak I, Szendrei L, Vecsernyes M, Varga E, Blasig IE, Tosaki A: Non-specific caspase inhibition reduces infarct size and improves post-ischaemic recovery in isolated ischaemic/reperfused rat hearts. Naunyn Schmiedebergs Arch Pharmacol, 2001, 364, 501-507.
15. Kovalovich K, Li W, DeAngelis R, Greenbaum LE, Ciliberto G, Taub R: Interleukin-6 protects against Fasmediated death by establishing a critical level of antiapoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J Biol Chem, 2001, 276, 26605-26613.
16. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML: Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation, 1995, 92, 1866-1875.
17. Lien R, Flaisher-Grinberg S, Cleary C, Hejny M, Einat H: Behavioral effects of Bcl-2 deficiency: implications for affective disorders. Pharmacol Rep, 2008, 60, 490-498.
18. Luc G, Bard JM, Juhan-Vague I, Ferrieres J, Evans A, Amouyel P, Arveiler D et al.: C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study. Arterioscler Thromb Vasc Biol, 2003, 23, 1255-1261.
19. Mysliwiec J, Zbucki R, Winnicka M, Sawicki B, Nikolajuk A, Kaminski K, Mysliwiec P et al.: Interleukin-6 is not essential for bone turnover in hypothyroid mice. Folia Histochem Cytobiol, 2007, 45, 387-392.
20. Negoro S, Kunisada K, Tone E, Funamoto M, Oh H, Kishimoto T, Yamauchi-Takihara K: Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc Res, 2000, 47, 797-805.
21. Rollwagen FM, Madhavan S, Singh A, Li YY, Wolcott K, Maheshwari R: IL-6 protects enterocytes from hypoxia-induced apoptosis by induction of bcl-2 mRNA and reduction of fas mRNA. Biochem Biophys Res Commun, 2006, 347, 1094-1098.
22. Schieffer B, Selle T, Hilfiker A, Hilfiker-Kleiner D, Grote K, Tietge UJ, Trautwein C et al.: Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation, 2004, 110, 3493-3500.
23. Song M, Kellum JA: Interleukin-6. Crit Care Med, 2005, 33, S463-465.
24. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB et al.: Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation, 2003, 107, 1486-1491.
25. Ward NS, Waxman AB, Homer RJ, Mantell LL, Einarsson O, Du Y, Elias JA: Interleukin-6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol, 2002, 22, 535-542.